ArticleChildren (Basel, Switzerland)2026
Medical Diagnosis, ED Visits, and Hospitalizations for Substance Use in U.S. Children's Hospitals: A Retrospective Multi-Center Cohort Study.
Article in Children (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
BACKGROUND/
objectivesAdolescents with chronic medical conditions (A-CMCs) are at increased risk for alcohol and other drug (AOD) use and adverse health outcomes. However, little is known about patterns of AOD-related emergency department (ED) visits and hospitalization among A-CMCs. This study investigates ED patterns and associations between AOD use, chronic medical complexity, and race-ethnicity with hospitalization following ED visits. AOD use was categorized into three groups: mainstream substances (e.g., cannabis), illicit/other psychoactive substances (e.g., opioids), and no documented AOD diagnosis. A-CMCs were divided into two groups: chronic conditions (CC) or complex chronic conditions (CCC).
methodsA retrospective cohort of ED encounters among A-CMCs was analyzed. Data were derived from 45 U.S. children's hospitals participating in the Pediatric Health Information System from 2021 to 2023. Associations were examined using logistic regression, adjusting for covariates.
resultsThe cohort included 1,098,496 ED visits among A-CMCs (encounter-level counts, which may include repeat visits by the same A-CMC); 72.9% of encounters involved adolescents with CCs (27.1% with CCCs).4.2% of those visits were AOD-related, with most involving mainstream substances in CCs and CCCs groups (78.0% and 76.3%, respectively; DISCUSSION/
conclusionsAmong A-CMCs, AOD-related ED visits-involving either mainstream or illicit/other psychoactive substances-were associated with increased adjusted odds of hospitalization relative to visits with no documented AOD diagnosis, with mainstream substances accounting for the majority of AOD-related encounters overall. Racial-ethnic differences in hospitalization were observed and may reflect a range of clinical and contextual factors not measured in this study, underscoring the need for standardized AOD screening and evaluation in pediatric settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.